The limitations of biomarkers in addressing bias in alcohol and cardiovascular disease research
This commentary refers to ‘Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial’, by I. Domínguez-López et al., https://doi.org/10.1093/eurheartj/ehae804.
Authors
- Shantanu Srivatsa (ORCID: https://orcid.org/0000-0002-9398-8358)
- Michael E. Farkouh (ORCID: https://orcid.org/0000-0002-8095-0246)
- Elizabeth K. Farkouh (ORCID: https://orcid.org/0000-0002-7379-058X)
Institutions
- University of North Carolina at Chapel Hill (US)
- Mayo Clinic (US)
- University of North Carolina Health Care (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Sinai Health System (US)
Publication Details
- Journal
- European Heart Journal
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1093/eurheartj/ehaf548
- Citations
- 1
- Primary Topic
- Alcohol Consumption and Health Effects
- Type
- article
- Field-Weighted Citation Impact
- 1.47